Chinagene Tech
Chinagene Tech is an ophthalmology clinical genetic diagnosis organization
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Chinagene Tech Information
Geographic Data
Address:
City: Changping
State: Beijing
Zip:
Country: China
Financial Info
Stage:
series a
Raised Last:
$16M
Raised Total:$28M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company&s;s clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2022 | Series A | 4 | $15.8M |
HY Capital Junci Investment Longqian Capital Yingke Capital HY Capital Junci Investment Longqian Capital Yingke Capital |
3/2021 | Seed Round | $0 |
Longmen Capital Lotus Lake Ventures Longmen Capital Lotus Lake Ventures |
3/2019 | Corporate Round | 4 | $1.5M |
Beijing Shoukai Kaiyang Venture Capital Center Chiron Ventures Cowin Capital Puhua Capital Beijing Shoukai Kaiyang Venture Capital Center Chiron Ventures Cowin Capital Puhua Capital |
3/2021 | Seed Round | 2 | $10.7M |
Longmen Capital Lotus Lake Ventures Longmen Capital Lotus Lake Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
